iTech project will target people under the age of 30, the population with most new HIV infections in US. The effort is led by Lisa Hightow-Weidman, MD, MPH, associate professor of medicine.
A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.
Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission according to the groundbreaking study led by Myron Cohen, MD.
Findings contradict previous studies questioning the relevance of these cells
A recent gathering in the UNC Infectious Disease Clinic served as a reunion for the nurses and other medical staff who worked tirelessly to care for patients in the early days of the HIV/AIDS epidemic and ultimately led to the establishment of a dedicated clinic within the hospital for those patients.
Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner
These findings demonstrate that antiretroviral therapy, when taken until viral suppression is achieved and sustained, is a highly effective, durable intervention for HIV prevention.
The HIV Cure center will be located on the UNC-Chapel Hill campus and will focus exclusively on finding a cure for HIV/AIDS.
A new study in PLoS Pathogens shows that HIV can infect the brain early on and should be combated as soon as possible with antiretroviral therapy to limit risk of dementia
Dr. David Wohl, an HIV/AIDS specialist at UNC, reflects on the reasons why he now finds himself drawn to fighting Ebola.
UNC School of Medicine researcher David Margolis, MD, was one of the first researchers to resist the common view that HIV is an incurable infection
Supporting Operational AIDS Research (SOAR) is a global research project to determine how best to address challenges and gaps that remain in the delivery of HIV and AIDS care and support, treatment, and prevention services.
The University of North Carolina at Chapel Hill has received a $1.5 million grant aimed at strengthening HIV/AIDS research training in collaboration with the Wits School of Public Health at the University of the Witwatersrand in Johannesburg, South Africa.
Several members of the UNC School of Medicine faculty had articles published in the Journal of the American Medical Association's (JAMA) July 23/30, 2014, HIV/AIDS theme issue.
The School ranked 2nd in Primary Care and 22nd in Research overall in the 2015 U.S. News & World Report Best Medical School Rankings. Family Medicine, Rural Medicine and AIDS were also listed as top ten specialties.
UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.
More than 22,000 inmates entering North Carolina prisons in 2008 and 2009 were tested for HIV, but only 20 new cases of HIV were found.
Previous recipients include Maya Angelou, Charles Kuralt, Charlie Rose and Oliver Smithies.
The Daily Dose app will utilize game mechanics and social networking features to improve adherence to HIV medication.
As we approach National HIV/AIDS Testing Day on June 27, a new call center will connect newly diagnosed North Carolinians with HIV care providers.